Log in

VanEck Vectors Pharmaceutical ETF Stock Price, Forecast & Analysis (NYSEARCA:PPH)

$61.11
+0.28 (+0.46 %)
(As of 11/22/2019 08:00 AM ET)
Add
Today's Range
$60.79
Now: $61.11
$61.24
50-Day Range
$54.72
MA: $58.28
$61.54
52-Week Range
$52.39
Now: $61.11
$62.90
Volume25,400 shs
Average Volume52,824 shs
Market Capitalization$173.43 million
P/E RatioN/A
Dividend Yield1.92%
BetaN/A

Basic Details

Issuer Van Eck
Fund NameVanEck Vectors Pharmaceutical ETF
Tax ClassificationRegulated Investment Company
SymbolNYSEARCA:PPH
Inception Date12/20/2011
Fund ManagerHao-Hung Peter Liao, Guo Hua Jason Jin
PhoneN/A

Fund Focus

Asset ClassEquity
BenchmarkMarket Vectors US Listed Pharmaceutical 25 Index
CategorySector
FocusHealth Care
Development LevelDeveloped Markets
RegionGlobal

Fund Statistics

Assets Under Management$172.76 million
Average Daily Volume$50,025.60
Discount/Premium-0.04%

ETF Expenses

Management Fee0.35%
Other Expenses0.05%
Total Expenses0.40%
Fee Waiver-0.05%
Net Expenses0.35%

Administrator, Advisor and Custodian

AdministratorVan Eck Associates Corporation
AdvisorVan Eck Associates Corporation
CustodianThe Bank of New York Mellon Corporation
DistributorVan Eck Securities Corporation
Transfer AgentThe Bank of New York Mellon Corporation
Trustee
Lead Market MakerIMC Chicago

Receive PPH News and Ratings via Email

Sign-up to receive the latest news and ratings for PPH and its competitors with MarketBeat's FREE daily newsletter.


Geographic Exposure of VanEck Vectors Pharmaceutical ETF (NYSEARCA:PPH)
Currency Exposure of VanEck Vectors Pharmaceutical ETF (NYSEARCA:PPH)
Sector Exposure of VanEck Vectors Pharmaceutical ETF (NYSEARCA:PPH)
Industry Exposure of VanEck Vectors Pharmaceutical ETF (NYSEARCA:PPH)

VanEck Vectors Pharmaceutical ETF (NYSEARCA:PPH) Frequently Asked Questions

What is VanEck Vectors Pharmaceutical ETF's stock symbol?

VanEck Vectors Pharmaceutical ETF trades on the New York Stock Exchange (NYSE)ARCA under the ticker symbol "PPH."

How often does VanEck Vectors Pharmaceutical ETF pay dividends? What is the dividend yield for VanEck Vectors Pharmaceutical ETF?

VanEck Vectors Pharmaceutical ETF announced a quarterly dividend on Monday, April 1st. Shareholders of record on Tuesday, April 2nd will be given a dividend of $0.39 per share on Friday, April 5th. This represents a $1.56 annualized dividend and a dividend yield of 2.55%. The ex-dividend date of this dividend is Monday, April 1st. This is a boost from VanEck Vectors Pharmaceutical ETF's previous quarterly dividend of $0.20. View VanEck Vectors Pharmaceutical ETF's Dividend History.

Has VanEck Vectors Pharmaceutical ETF been receiving favorable news coverage?

Media headlines about PPH stock have trended negative recently, InfoTrie reports. InfoTrie identifies negative and positive news coverage by monitoring more than six thousand blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. VanEck Vectors Pharmaceutical ETF earned a media sentiment score of -2.5 on InfoTrie's scale. They also assigned media coverage about the company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an impact on the stock's share price in the near future. View News Stories for VanEck Vectors Pharmaceutical ETF.

What other stocks do shareholders of VanEck Vectors Pharmaceutical ETF own?

Based on aggregate information from My MarketBeat watchlists, some companies that other VanEck Vectors Pharmaceutical ETF investors own include Intel (INTC), Icon (ICLR), Gilead Sciences (GILD), FOX (FOX), Fonar (FONR), Cisco Systems (CSCO), Cirrus Logic (CRUS), Costco Wholesale (COST), Comcast (CMCSA) and Amgen (AMGN).

Who are VanEck Vectors Pharmaceutical ETF's major shareholders?

VanEck Vectors Pharmaceutical ETF's stock is owned by many different of institutional and retail investors. Top institutional investors include Oppenheimer & Co. Inc. (0.37%), North Star Investment Management Corp. (0.10%) and Tower Research Capital LLC TRC (0.05%).

Which major investors are selling VanEck Vectors Pharmaceutical ETF stock?

PPH stock was sold by a variety of institutional investors in the last quarter, including Tower Research Capital LLC TRC and Oppenheimer & Co. Inc..

Which major investors are buying VanEck Vectors Pharmaceutical ETF stock?

PPH stock was acquired by a variety of institutional investors in the last quarter, including North Star Investment Management Corp..

How do I buy shares of VanEck Vectors Pharmaceutical ETF?

Shares of PPH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is VanEck Vectors Pharmaceutical ETF's stock price today?

One share of PPH stock can currently be purchased for approximately $61.11.

How big of a company is VanEck Vectors Pharmaceutical ETF?

VanEck Vectors Pharmaceutical ETF has a market capitalization of $173.43 million. View Additional Information About VanEck Vectors Pharmaceutical ETF.

What is VanEck Vectors Pharmaceutical ETF's official website?

The official website for VanEck Vectors Pharmaceutical ETF is http://www.vaneck.com/.


MarketBeat Community Rating for VanEck Vectors Pharmaceutical ETF (NYSEARCA PPH)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  34 (Vote Outperform)
Underperform Votes:  33 (Vote Underperform)
Total Votes:  67
MarketBeat's community ratings are surveys of what our community members think about VanEck Vectors Pharmaceutical ETF and other stocks. Vote "Outperform" if you believe PPH will outperform the S&P 500 over the long term. Vote "Underperform" if you believe PPH will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 11/22/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel